Patient Advocates Working Group Chair
Bettina Ryll is a patient advocate and founding member of the Independent Melanoma Community Advisory Board. A qualified doctor, with a PhD in molecular biology, she gained a deeper insight into the reality of cancer, and fighting cancer, when her husband Peter was diagnosed with advanced melanoma. She now uses that insight to help others.
She holds a MBBS and PhD in Biomedical Sciences- Molecular Biology with special interest in gene regulation and the interface of Molecular Biology and Medicine.
She is the founder of new network of European Melanoma patient advocates with the aim to systematically and pragmatically address the problems the European Melanoma community is facing in a constructive, result-orientated and collaborative manner, in particular patient participation in clinical research, patient-centred clinical trial design and alternative licensing models.
ESMO 2016 Congress
"The ultimate purpose of healthcare is to benefit patients, so patients are the ultimate data source from where to learn whether we reach this goal. Patient Advocates thereby play a crucial mediator role between patients and other stakeholders. ESMO 2016 will offer patient advocates the opportunity to attend both dedicated advocacy sessions and scientific sessions in their field of interest, providing a valuable educational opportunity and promoting excellence in advocacy."
Bettina Ryll is the ESMO Patient Advocacy Working Group Chair of the ESMO 2016 Congress, taking place in Copenhagen, Denmark (7-11 October, 2016).
See who the other ESMO 2016 Congress Officers are!